{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles all mention \"Lockdown\" but the passages are either empty or just \"Lockdown\" again. The only meaningful part is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe that's a typo or a fragment.\n\nFirst, I need to define a lockdown. A lockdown is typically a strict set of measures imposed by authorities to restrict movement and gatherings to control the spread of a disease, like during a pandemic. Since the context mentions lockdown in the titles and the date 24/3/2020, which is March 24, 2020, that's when many countries started lockdowns due to COVID-19. The mention of \"banned Implemented with lockdown\" might refer to certain measures being banned or enforced as part of the lockdown. \n\nBut the user's question is straightforward, so I should provide a clear definition. The context doesn't have much info, so I'll rely on general knowledge. I should explain that a lockdown involves restricting people's movements, closing non-essential businesses, schools, and public places, and enforcing social distancing. The goal is to reduce the spread of infectious diseases. Since the context is about estimating infections, the impact of lockdowns would be part of that analysis. \n\nWait, the user might be expecting an answer based solely on the provided context. The context has repeated titles and a fragment. The only useful part is \"banned Implemented with lockdown.57 24/3/2020\". Maybe \"banned\" refers to certain activities being prohibited during the lockdown. The date is March 24, 2020, which is when the UK announced a strict lockdown. So perhaps the answer should mention that a lockdown is a set of restrictions implemented to limit movement and gatherings, as part of measures to control the spread of infections, as seen in the example from March 24, 2020. \n\nI need to make sure the answer is concise and uses the context if possible. Since the context is limited, I'll combine the general definition with the date mentioned. So the answer would be: A lockdown is a set of strict measures implemented to restrict movement and gatherings, often enforced during a pandemic",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know is the Chikungunya virus. Let me look through the provided context to find all the mentioned complications.\n\nFirst, in the first passage, there's a list of complications from most common to least common. They mention respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. So those are the main ones listed in order.\n\nThen, looking at the second passage, there's information about neonatal complications. It says that mothers can transmit CHIKV to their babies during the perinatal period, leading to high morbidity. The neonates became symptomatic by Day 4, showing common CHIKF symptoms. Six neonates had CHIKV and developed meningoencephalitis. There's also mention of nineteen cases of neonatal infection leading to encephalitis due to vertical transmission. Additionally, there were three fetal deaths reported when mothers were infected long before delivery during the La Reunion Island epidemic.\n\nSo putting this all together, the complications include both the general ones listed in the first part and the neonatal-specific issues like encephalitis and fetal deaths. I need to make sure I include all these points in the answer. Also, note that meningoencephalitis is mentioned both in the general list and specifically in neonates. The answer should list all the complications from both passages without missing any. Let me check again to ensure I didn't overlook anything. The first passage lists seven complications, and the second adds neonatal encephalitis, vertical transmission leading to encephalitis, and fetal deaths. I should present them clearly, maybe grouping the neonatal complications separately for clarity.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include:  \n1. **Common complications in adults** (from most to least common):  \n   - Respiratory failure  \n   - Cardiovascular decompensation  \n   - Meningoencephalitis  \n   - Severe acute hepatitis  \n   - Severe cutaneous effects  \n   - Other central nervous system problems  \n   - Kidney failure  \n\n2. **Neonatal complications** (from vertical transmission):  \n   - High morbidity in neonates, with symptoms appearing by Day 4 of life.",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "Passage: and complications.",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported ."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I notice mentions of clades like 1B.1, 1B.2, 1C.2, 1A.1, and 1A.1.1. However, there's no direct mention of \"Clade A\" in the given text. The titles and passages refer to different lineages such as 1B human seasonal lineage, 1C swine lineage, and their subdivisions.\n\nThe first passage talks about clades with APD (Average Pairwise Distance) criteria. It mentions exceptions like 1B.1 and 1B.2, and later the 1A.1 and 1A.1.1 clades as within-clade exceptions. The second passage discusses the 1C lineage, which includes viruses from China and South Korea, and mentions \"Other-Avian\" clades. \n\nSince the question is about Clade A, but the text refers to clades starting with numbers like 1A.1, 1B, 1C, etc., it's possible that \"Clade A\" isn't explicitly defined here. The user might be confusing the nomenclature. The text uses a numerical system (like 1A.1, 1B.1) rather than just \"A\". Alternatively, maybe \"Clade A\" refers to the first-order clades like 1A.1? But the answer isn't directly stated. Since there's no information on a standalone Clade A, the answer might be that it's not mentioned in the provided context. Alternatively, perhaps the user made a typo and meant 1A.1? But the question specifically says Clade A. Given the information, I should conclude that Clade A isn't discussed here, or maybe the answer is that there's no Clade A in the provided context.\n</think>\n\nThe provided context does not explicitly mention a \"Clade A.\" Instead, it references clades with numerical designations such as **1A.1**, **1B.1**, **1B.2**, **1C.2**, and others, which are part of broader lineages (e.g., 1C swine lineage). The text discusses exceptions and APD criteria for these specific clades but does",
      "retrieved_chunks": [
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the context also says that unlike 2019-nCoV and human SARS-CoV, most bat SARS-related CoVs have two stretches of deletions in the spike receptor binding domain. So, the S1 subunit's RBD in 2019-nCoV is more similar to human SARS-CoV than to the bat versions, which have deletions.\n\nThe S2 subunit is highly conserved with 99% identity across the mentioned viruses, but the question is about S1. The answer should focus on the 70% identity for S1 and the conserved RBD core. Also, note that bat SARS-related CoVs have deletions in the RBD compared to human SARS-CoV and 2019-nCoV. \n\nSo putting it together: The S1 subunit of 2019-nCoV has about 70% identity with bat SARS-like CoVs and human SARS-CoV. The RBD core is conserved, but bat viruses have deletions there. The S1 is less conserved than S2, which is 99% identical. The answer should mention the 70% identity and the conserved RBD despite the deletions in bat viruses.\n</think>\n\nThe S1 subunit of 2019-nCoV shares approximately **70% identity** with the S1 subunits of bat SARS-like CoVs and human SARS-CoV. However, while the **core domain of the receptor binding domain (RBD)** in 2019-nCoV is highly conserved compared to human SARS-CoV, most bat SARS-related CoVs (e.g., ZC45) exhibit **two stretches of deletions** in their RBD when compared to human SARS",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's see. The user is asking \"What is Bacillus subtilis?\" and I need to answer based on the provided context.\n\nFirst, I'll look through the context given. The context mentions that Bacillus subtilis produces surfactins, fengycins, and iturins in a specific ratio. It also talks about Bacillus species being part of probiotics and their role in the intestinal microbiome. The titles and passages discuss the secretome of intestinal bacilli as a natural guard against pathologies. \n\nBacillus subtilis is a species within the Bacillus genus. The context says that unlike Lactobacillus, Bacillus wasn't considered part of the normal intestinal microbiome but has been found in feces. They are used in probiotics like Biosubtyl, Biosporin, etc. Also, their secretions (surfactins, etc.) have antimicrobial and antiviral properties. \n\nSo putting this together, Bacillus subtilis is a probiotic bacterium that produces various lipopeptides with health benefits. It's part of the Bacillus genus, used in probiotics, and contributes to intestinal health by producing antimicrobial substances. The answer should mention its role in probiotics, the specific compounds it produces, and its function in protecting against pathogens.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus, known for producing bioactive lipopeptides such as surfactins, fengycins, and iturins (in a ratio of 6:37:57). These compounds exhibit antimicrobial, antiviral, and protective properties, contributing to its role as a probiotic in maintaining intestinal health. Historically not classified as part of the normal intestinal microbiome, *B. subtilis* is now recognized for its presence in the gut and its use in commercial probiotics (e.g., Biosubtyl, Biosporin) to combat pathologies. Its secretome acts as a natural defense mechanism against pathogens, supporting intestinal function and overall health.",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.375,
      "computed_completeness": 0.5,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context: \"The origins of the great pandemic\" mentions the 1889 pandemic with three major waves, but the user is interested in single-wave pandemics. However, it also talks about the 1918 pandemic's herald waves possibly starting in 1915. The 1918 pandemic is known for having multiple waves, so maybe not directly relevant here. But the mention of viruses with identical genome sequences before the fall wave might relate to understanding pandemic origins, which could be part of research on single-wave scenarios if they had only one major wave.\n\nNext, the Hong Kong study on 2009 pH1N1 discusses convalescent plasma treatment and models. The passage mentions a multi-wave epidemic (from the Richards model variation in the Taiwan study), but the user wants single-wave. However, the 2009 pandemic itself had multiple waves in some regions, but maybe in certain areas it was a single wave? The context doesn't specify, so maybe not directly applicable.\n\nThe Taiwan study talks about multi-wave epidemics, using a model that distinguishes between waves. Since the question is about single-wave, this might not be directly relevant unless they compared single vs. multi-wave scenarios. The study's focus is on multi-wave, so probably not helpful here.\n\nThe economic analysis study mentions five pandemic severity categories and mitigation strategies. It doesn't specifically address single-wave pandemics but looks at different severities. Not directly answering the question.\n\nLooking back, the 1889 pandemic had three waves, but the user wants single-wave. The 1918 pandemic is mentioned with possible herald waves but again multiple waves. The 2009 pH1N1 is discussed in terms of multi-wave in some contexts. However, maybe the research on the 2009 pandemic in Hong Kong and Taiwan considered single-wave scenarios? The Hong Kong passage mentions a pandemic (2009) and convalescent plasma, but the Taiwan study specifically talks about multi-wave. \n\nWait, the first context's passage says that viruses with identical sequences to the fall wave were circulating in early 1918 before the pandemic was recognized. If the 1918 pandemic had herald",
      "retrieved_chunks": [
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.875,
      "computed_utilization": 0.875,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the given context. The user is asking for the number of reported viral pneumonia cases, but the context provided includes several passages about different topics related to influenza and pneumonia, including some about the 2009 H1N1 pandemic and the 2019-nCoV (which is COVID-19). \n\nFirst, I need to look through each passage to see if any mention the number of viral pneumonia cases. Let's go through each one step by step.\n\nThe first passage talks about bacterial co-infection in the 2009 H1N1 pandemic. It mentions that 29% of 77 fatal cases had concurrent bacterial pneumonia. But this is about bacterial co-infection, not the total viral pneumonia cases. So this might not directly answer the question, but maybe it's part of a larger number.\n\nThe second passage discusses influenza attack rates during seasonal epidemics and the 2009 H1N1 pandemic in La Gloria. It gives percentages of attack rates but not specific numbers of pneumonia cases. The numbers here are about infection rates, not specifically pneumonia.\n\nThe third passage is about pneumonia in adults hospitalized with seasonal influenza in the US from 2005\u20132008. It mentions that patients with pneumonia were more likely to receive antiviral therapy, but again, it's about treatment, not the count of cases.\n\nThe fourth passage is about 2019-nCoV (COVID-19) confirmed cases in China as of January 26, 2020. It states 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems directly relevant because it's about viral pneumonia caused by a coronavirus. However, the question is about \"viral pneumonia\" in general. But since the context includes this specific number, maybe that's the answer they're looking for. \n\nWait, the question is \"How many reported viral pneumonia?\" The context mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection. Since 2019-nCoV is a virus, those cases would be viral pneumonia. So that's a direct number. Are there other numbers in the context? Let me check again.\n\nThe first passage mentions 77 fatal cases of H1N1, but",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage talks about single nucleotide differences and specific proteins, but doesn't mention the method used. The third passage mentions whole genome sequencing being used extensively, but that's part of the same context as the first answer. The fourth passage discusses genetic recombination studies but again doesn't mention the primary method. \n\nSo the main answer is definitely the high throughput or deep sequencing methods. The user might be looking for confirmation that this is the primary technique used in MERS-CoV genetic analysis. I should present the answer clearly, quoting the exact method from the first passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "Among all humans reported to be infected, nearly 40 % have died."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the methods mentioned.\n\nFirst, the context mentions that one color channel was imaged, showing GFP-expressing cells in white and others in black. Then they used immunofluorescence microscopy with a GFP antibody during passaging. For generating single-cell clones, they used transduction and puromycin selection, then limiting dilution. \n\nIn the passage, they talk about infected mice lungs. They used IVIS for whole-organ imaging ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. Also, imaging of murine lungs showed infection starting near large airways and spreading deeper.\n\nSo the tracking methods would be IVIS for whole-organ imaging and flow cytometry. The answer should include both techniques. Let me check the exact wording from the passage again. The passage says \"Not only was GFP observable in the lungs of infected mice ex vivo using IVIS... but could also be observed using flow cytometry...\" So those are the two methods. The answer should mention both IVIS (which is in vivo imaging system) and flow cytometry. Also, the imaging showed the spread from airways to deeper parts. But the question is specifically about how they tracked the spread, so the methods are IVIS for whole-organ imaging and flow cytometry for analyzing cells. That's the answer.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **IVIS (in vivo imaging system)** for whole-organ imaging of murine lungs ex vivo and **flow cytometry** to analyze infection progression in antigen-presenting cells. These methods revealed that the infection initially localized near large conducting airways and later spread to deeper lung regions.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The answer should probably include steps like immediate disinfection, using appropriate sterilization methods, and maybe specific protocols for CT equipment.\n\nBut the context is a bit fragmented. The first passage says \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination.\" Wait, \"noncontaminated\" might be a typo or mistranslation. Maybe they meant \"contaminated\"? Or perhaps it's referring to procedures that prevent contamination. The second passage mentions \"fever-CT disinfection procedures after examination.\" The third passage talks about \"after these sterilization procedures\" and the fourth says \"prepares to disinfect the imaging equipment immediately after the examination.\"\n\nPutting this together, the recommended procedure seems to involve immediate disinfection of the CT scanner after an examination involving a suspected or confirmed COVID-19 case. The steps might include using specific sterilization protocols, ensuring all surfaces are disinfected, and possibly using appropriate personal protective equipment during the process. However, the exact details aren't provided in the context, so the answer should be based on the information given, which emphasizes immediate disinfection post-examination using established sterilization procedures.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment after the examination** using established sterilization protocols. The context emphasizes that disinfection should occur promptly following the examination of suspected or confirmed COVID-19 cases to prevent contamination. Specific steps likely include thorough cleaning of all surfaces and components of the CT equipment, adhering to guidelines for sterilization procedures tailored to medical imaging devices.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}